SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $35,000 | -58.8% | 15,766 | -63.8% | 0.00% | -66.7% |
| Q1 2015 | $85,000 | -49.1% | 43,591 | -30.9% | 0.00% | -50.0% |
| Q4 2014 | $167,000 | -30.7% | 63,123 | -21.0% | 0.01% | -14.3% |
| Q3 2014 | $241,000 | -31.3% | 79,927 | -7.0% | 0.01% | -22.2% |
| Q2 2014 | $351,000 | +663.0% | 85,937 | +703.0% | 0.01% | +800.0% |
| Q1 2014 | $46,000 | -47.7% | 10,702 | -36.3% | 0.00% | -66.7% |
| Q4 2013 | $88,000 | +31.3% | 16,802 | +58.5% | 0.00% | +50.0% |
| Q3 2013 | $67,000 | – | 10,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |